Phase 1 KRAS multi-inhibitor This compound is under investigation, further information will be available soon. Anchored in external partnership or acquisition Partnering inquiries Join our team Additional links Innovation in Oncology and Cancer Immunology Research Cancer Oncology and Cancer Immunology Partnering Interests “My ultimate goal is to cure cancer”
